SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Immdal Ltd Announces Sale of Subsidiary Newport

October 20, 2011 | 
1 min read
DUBLIN--(BUSINESS WIRE)--Immdal Limited (‘Immdal’), a privately held Irish pharmaceutical healthcare group, today announced the sale of its subsidiary Newport Pharmaceuticals Limited (‘Newport’) to Swiss pharmaceutical company Ewopharma AG.
Mergers & acquisitions Europe
MORE ON THIS TOPIC
Police officer and sheriff, standing on the egde of the cliff. Handmade painting, acrylic on paper & post processing.
Earnings
Sanofi targets late-phase and commercial M&A to offset looming Dupixent decline
October 30, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Robotic claw clutching a money stock illustration
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
October 29, 2026
 · 
2 min read
 · 
Gabrielle Masson
Contemporary art collage. Motivated, confident team go over light background with abstract object, red arrows. Concept of business development, teamwork, startup, finance, career.
Job Trends
Biopharma cuts at manufacturing plants expected to affect 4,000+
October 29, 2026
 · 
5 min read
 · 
Angela Gabriel
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
 · 
2 min read
 · 
Tristan Manalac